Tuberculosis News and Research

Latest Tuberculosis News and Research

New ReFRAME drug repurposing collection offers hope for treating major diseases

New ReFRAME drug repurposing collection offers hope for treating major diseases

Decibel obtains exclusive license to commercialize ORC-13661 for preventing hearing, balance disorders

Decibel obtains exclusive license to commercialize ORC-13661 for preventing hearing, balance disorders

NIAID releases strategic plan to expand knowledge of TB by using modern tools

NIAID releases strategic plan to expand knowledge of TB by using modern tools

Diabetes patients with poor blood sugar control face highest risk of serious infections

Diabetes patients with poor blood sugar control face highest risk of serious infections

New TB vaccine effective in half of the population in phase II trials

New TB vaccine effective in half of the population in phase II trials

‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms

‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

LSTM partners with TB Alliance to develop novel TB drug regimens

LSTM partners with TB Alliance to develop novel TB drug regimens

QIAGEN and DiaSorin launch automated, CE-marked workflow for high-throughput TB screening

QIAGEN and DiaSorin launch automated, CE-marked workflow for high-throughput TB screening

Inhaled steroid use linked to greater risk of NTM lung infections

Inhaled steroid use linked to greater risk of NTM lung infections

Scientists develop first non-antibiotic drug to treat tuberculosis in animals

Scientists develop first non-antibiotic drug to treat tuberculosis in animals

Effective vaccines for world's most prevalent infectious diseases are missing from pipeline

Effective vaccines for world's most prevalent infectious diseases are missing from pipeline

Study provides insights into how harmful white blood cells form during tuberculosis

Study provides insights into how harmful white blood cells form during tuberculosis

Around 8.4 million deaths occur each year from poor quality of care in low- and middle-income countries

Around 8.4 million deaths occur each year from poor quality of care in low- and middle-income countries

New Cochrane Review assesses accuracy of Xpert in diagnosing extrapulmonary TB

New Cochrane Review assesses accuracy of Xpert in diagnosing extrapulmonary TB

TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

New technique may provide continuous country-level surveillance of drug-resistant tuberculosis

New technique may provide continuous country-level surveillance of drug-resistant tuberculosis

Scientists gain new insight into the immune system and infections

Scientists gain new insight into the immune system and infections

New method identifies communities experiencing drug-resistant tuberculosis in South Africa

New method identifies communities experiencing drug-resistant tuberculosis in South Africa

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.